EXAS - Exact Sciences Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Exact Sciences Corporation

441 Charmany Drive
Madison, WI 53719
United States

IndustryDiagnostics & Research
Full Time Employees1,977

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin T. ConroyChairman, Pres & CEO1.51M27.76M1966
Mr. Jeffrey T. Elliott CFAChief Financial Officer643.82kN/A1978
Mr. Graham P. LidgardChief Science Officer744.93k1.51M1949
Mr. D. Scott CowardChief Admin. Officer, Sr. VP, Gen. Counsel & Sec.745.27kN/A1965
Mr. Mark StenhousePres of Cologuard952.26kN/A1967
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

Corporate Governance

Exact Sciences Corporation’s ISS Governance QualityScore as of October 4, 2019 is 6. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.